Novozymes B A/S
Novozymes B A/S
-0,63 %
347,60 DKK
-2,20
Kurs
347,60
Høj
352,80
Ændring
-0,63 %
Lav
347,40
Opdateret
21-09-2018
Åben
351,00
Nyheder om Novozymes B A/S
Factsheet for Novozymes B A/S
Company Profile
Description
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.
Key Stats
Website: http://www.novozymes.com
Headquarter country: Denmark
Employees: 6.112
Market Cap (at close 21-09-2018): DKK 101B
Fiscal Year Ends: december
Stats

Stats 2017 2016 2015 2014 2013
Price/Earnings 33,80 25,30 37,50 33,10 34,00
Forward Price/Earnings 30,70 22,40 30,90 33,20 30,60
Price/Free Cash Flow 42,10 29,70 53,50 18,40 44,70
Return on Assets 16,80 16,70 15,60 14,50 13,90
Return on Equity 27,10 26,20 24,70 22,60 21,30
Return on Invested Capital 23,00 23,10 21,70 19,60 18,40
Dividend


Dividend/Share:4,00
Ex. Dividend Date:31-12-2017
Trailing Dividend Yield:1,29
Payout Ratio:41,59
Date Currency Amount
31-03-2018 DKK 4,50
31-03-2017 DKK 4,00
31-03-2016 DKK 3,50
31-03-2015 DKK 3,00
31-03-2014 DKK 2,50
31-03-2013 DKK 2,20
Income Statement

Revenue 2017 2016 2015 2014 2013
Total Revenue 14.531 14.142 14.002 12.459 11.746
Gross Profit 8,41 8,13 8,13 7,15 6,72
Gross Margin % 57,90% 57,46% 58,06% 57,38% 57,18%
Operating Expenses 2017 2016 2015 2014 2013
EBITDA 4.943,00 4.886,00 4.605,00 4.203,00 3.563,00
Net income 3.119,00 3.050,00 2.823,00 2.526,00 2.200,00
Basic Earnings Per Share 10,56 10,15 9,23 8,10 7,01
Operating Income 4,11 3,95 3,88 3,15 2,90
Operating Margin % 28,30% 27,90% 27,74% 25,26% 24,70%
Cash Flow

Cash Flow 2017 2016 2015 2014 2013
Operating Cash Flow 4.063,00 3.840,00 3.339,00 4.525,00 2.599,00
Capital Expenditures -1.692,00 -1.216,00 -1.031,00 -723,00 -786,00
Free Cash Flow 2.371,00 2.624,00 2.308,00 3.802,00 1.813,00
Balance Sheet

Assets 31-12-2017 31-12-2016 31-12-2015 31-12-2014 31-12-2013
Current Assets 6.137.000 6.393.000 6.148.000 7.311.000 5.830.000
Long Term Assets 12.236.000 12.266.000 11.643.000 11.115.000 10.676.000
Total Assets 18.373.000 18.659.000 17.791.000 18.426.000 16.506.000
Liabilities 31-12-2017 31-12-2016 31-12-2015 31-12-2014 31-12-2013
Total Current Liabilities 4.577.000 3.562.000 3.300.000 3.941.000 2.599.000
Long Term Liabilities 2.542.000 3.365.000 2.911.000
Total Liabilities 7.119.000 6.927.000 6.211.000
Equity 31-12-2017 31-12-2016 31-12-2015 31-12-2014 31-12-2013
Retained Earnings 10.861.000 10.483.000 10.396.000 10.209.000 10.246.000
Treasury Stock
Total Stockholder Equity 11.254.000 11.732.000 11.580.000 11.269.000 11.054.000
Net Tangible Assets 8.822.000 8.995.000 8.904.000 8.315.000 8.190.000